Stocktoria
111, Inc. YI
Nasdaq · XNAS · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 2018-09-12
Chart by TradingView
2/9
Piotroski F — financial health
-5.73
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $1.8B | $2.0B | $2.1B | $2.0B | $1.9B |
| Gross profit | $723.4M | $829.2M | $849.0M | $840.0M | $621.1M |
| Operating income | -$340,000 | $289,000 | -$49.3M | -$53.8M | -$100.8M |
| Operating cash flow | $17.0M | $36.0M | -$63.0M | -$3.4M | -$108.1M |
| Free cash flow | $16.4M | $34.0M | -$64.4M | -$7.9M | -$117.9M |
| Total assets | $314.6M | $381.9M | $435.1M | $503.7M | $493.6M |
| Total liabilities | $284.0M | $329.8M | $396.2M | $409.7M | $360.5M |
| Shareholders' equity | -$103.2M | -$90.2M | -$82.2M | -$59.3M | -$23.9M |
| Ratios | |||||
| Gross margin | 40.3% | 42.0% | 40.3% | 42.9% | 31.9% |
| Operating margin | -0.0% | 0.0% | -2.3% | -2.7% | -5.2% |
| FCF margin | 0.9% | 1.7% | -3.1% | -0.4% | -6.0% |
| Current ratio | 1.09 | 1.13 | 1.07 | 1.19 | 1.32 |
| Revenue growth | -9.0% | -6.3% | 7.4% | 0.5% | 55.1% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 13,014 | $84,851 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -5.73 (distress)
- Working capital / assets 0.078
- Retained earnings / assets -1.795
- EBIT / assets -0.001
- Equity / liabilities -0.363
Sector peers
WMT · CVS · COST · JD · HD · KR · all Retail Trade →
Source: SEC EDGAR filings · CIK 0001738906 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.